文献速递神经肿瘤

MRI定义的全切除在不同脑膜瘤DNA甲基化分组中的影响:分子分类时代重新评估手术作用

The Impact of MRI-Defined Extent of Resection Across Meningioma DNA Methylation Groups: Re-Evaluating Surgery in the Era of Meningioma Molecular Classification.
PubMed 文献 · Neurosurgery · 2025-01-07

本研究回顾性分析多中心国际队列中587例散发性脑膜瘤患者的644次手术,按术后MRI分为全切除(GTR)与次全切除(STR),并按DNA甲基化分为Merlin完整型、免疫富集型和高分裂型。结果显示GTR与所有甲基化分组更长的局部无复发生存相关,仅在高分裂型中与更长总生存相关(HR 0.64,95%CI 0.43-0.97,P=0.034)。

要点

  • GTR与所有DNA甲基化分组更长的局部无复发生存相关。
  • GTR仅在高分裂型脑膜瘤中与更长总生存相关(HR 0.64,95%CI 0.43-0.97,P=0.034)。
  • 多变量分析中EOR与所有甲基化分组和WHO级别的LFFR显著相关。

核心结论

  • MRI定义的GTR与所有脑膜瘤DNA甲基化分组更长的局部无复发生存相关,并与高分裂型患者更长的总生存相关。
  • 这些数据继续支持在可行时行最大安全切除,并表明分子分类系统补充而非取代手术的预后影响。

研究设计与样本

  • 多中心国际队列回顾性研究,纳入587例散发性脑膜瘤患者共644次颅内脑膜瘤手术。
  • 按术后MRI判定全切除(GTR)438次与次全切除(STR)206次,其中124次(19.3%)为复发性颅内脑膜瘤手术。
  • 组织学分级为WHO 1级375例(58.2%)、2级202例(31.4%)、3级67例(10.4%)。
  • DNA甲基化分组为Merlin完整型214例(33.2%)、免疫富集型236例(36.6%)、高分裂型194例(30.1%)。
  • 采用Kaplan-Meier法、log-rank检验和多变量Cox比例风险分析评估EOR对局部无复发生存(LFFR)和总生存(OS)的影响。

主要发现

  • GTR与所有DNA甲基化分组更长的LFFR相关(Merlin完整型P<.0001;免疫富集型P=.013;高分裂型P=.001)。
  • GTR与高分裂型脑膜瘤更长的OS相关(P=.0022)。
  • 多变量Cox分析中,EOR与所有DNA甲基化分组和WHO级别的LFFR显著相关。
  • 多变量Cox分析中,EOR仅与高分裂型脑膜瘤的OS显著相关(GTR vs STR的风险比0.64,95%CI 0.43-0.97,P=.034)。

临床怎么用

  • 作者认为这些数据继续支持在可行时行最大安全切除。
  • 作者认为分子分类系统补充而非取代手术的预后影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Extent of resection (EOR) is prognostic for meningioma outcomes. DNA methylation profiling can shed light on biological drivers and therapeutic vulnerabilities. The goal of this study was to re-evaluate the impact of EOR on clinical outcomes across meningioma DNA methylation groups. METHODS: Patients with sporadic meningiomas who underwent resection from a multicenter, international cohort were retrospectively reviewed. Gross vs subtotal resection (GTR vs STR, respectively) was determined based on postoperative MRI. The Kaplan-Meier method, log-rank statistics, and multivariable Cox proportional hazard analyses were performed to evaluate the impact of EOR on local freedom from recurrence (LFFR) and overall survival (OS). RESULTS: In total, 587 patients (Male: 195, Female: 392) underwent 644 surgeries for intracranial meningioma (GTR: 438, STR: 206), with 124 surgeries (19.3%) for recurrent intracranial meningiomas. The cohort included 375 (58.2%) World Health Organization (WHO) Grade 1, 202 (31.4%) WHO Grade 2, and 67 (10.4%) WHO Grade 3 meningiomas based on histological criteria. DNA methylation profiling was used to categorize meningiomas as Merlin-intact (N = 214, 33.2%), Immune-enriched (N = 236, 36.6%), or Hypermitotic (N = 194, 30.1%). GTR was associated with longer LFFR across all meningioma DNA methylation groups (Merlin-intact P < .0001; Immune-enriched P = .013; Hypermitotic P = .001) and was associated with longer OS for Hypermitotic meningiomas ( P = .0022). In multivariable Cox proportional hazard analyses, EOR was significantly associated with LFFR across all DNA methylation groups and WHO grades but was significantly associated with OS only for Hypermitotic meningiomas (hazard ratio [GTR vs STR] 0.64, 95% CI 0.43-0.97, P = .034). CONCLUSION: MRI-defined GTR is associated with improved LFFR across all meningioma DNA methylation groups and improved OS for patients with Hypermitotic meningiomas. These data continue to support maximal safe resection when feasible and demonstrate how molecular classification systems complement rather than supersede the prognostic impact of surgery.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Morshed RA, Nguyen MP, Choudhury A, et al. The Impact of MRI-Defined Extent of Resection Across Meningioma DNA Methylation Groups: Re-Evaluating Surgery in the Era of Meningioma Molecular Classification. Neurosurgery. 2025. PMID: 39773932. doi:10.1227/neu.0000000000003324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。